In addition, PEDF-34 mimics the activity of full length PEDF but can be delivered through eye drops, making it an attractive molecule for therapy since it reduces the need for intravitreal injections and thus alleviates pain and the risk of infection. The gene discussed is SERPINF1; the disease is infection.